tradingkey.logo
tradingkey.logo
Search

STAAR Surgical Co

STAA
Add to Watchlist
27.790USD
-0.360-1.28%
Close 07/02, 13:00ETQuotes delayed by 15 min
1.38BMarket Cap
LossP/E TTM

More Details of STAAR Surgical Co Company

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. The Company markets and sells its ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. Its EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company's newest offering, EVO Viva, has an extended depth of focus (EDoF) optic, which is designed to treat myopia with presbyopia (age-related loss of ability to focus). It also market and sell an ICL lens to treat hyperopia (farsightedness), called Visian ICL. It makes its ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision). The Company’s principal products are ICLs used in refractive surgery, including its EVO family of lenses.

STAAR Surgical Co Info

Ticker SymbolSTAA
Company nameSTAAR Surgical Co
IPO dateFeb 24, 1992
CEOFarrell (Stephen C)
Number of employees1157
Security typeOrdinary Share
Fiscal year-endFeb 24
Address1911 Walker Ave
CityMONROVIA
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code91016
Phone16263037902
Websitehttps://www.staar.com/
Ticker SymbolSTAA
IPO dateFeb 24, 1992
CEOFarrell (Stephen C)

Company Executives of STAAR Surgical Co

Name
Name/Position
Position
Shareholding
Change
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
82.21K
+57.24%
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
78.19K
+13.66%
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
69.54K
+18.35%
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
33.42K
+25.17%
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
30.18K
+72.87%
Ms. Deborah J. Andrews
Ms. Deborah J. Andrews
Chief Financial Officer
Chief Financial Officer
18.65K
+53.97%
Mr. Louis E. (Lou) Silverman
Mr. Louis E. (Lou) Silverman
Independent Director
Independent Director
11.16K
+95.74%
Dr. Elizabeth Yeu, M.D.
Dr. Elizabeth Yeu, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
5.10K
--
Mr. Brian Moore
Mr. Brian Moore
Vice President - Investor Relations and Corporate Development
Vice President - Investor Relations and Corporate Development
--
--
Ms. Lilian Zhou
Ms. Lilian Zhou
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
82.21K
+57.24%
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
78.19K
+13.66%
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
69.54K
+18.35%
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
33.42K
+25.17%
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
30.18K
+72.87%
Ms. Deborah J. Andrews
Ms. Deborah J. Andrews
Chief Financial Officer
Chief Financial Officer
18.65K
+53.97%

FAQs

Who are the top five shareholders of STAAR Surgical Co?

The top five shareholders of STAAR Surgical Co are: Mr. Stephen C. (Steve) Farrell, CPA

How many institutions hold shares of STAAR Surgical Co (STAA)?

As of 2026Q1, 543 institutions hold shares of STAAR Surgical Co, with a combined market value of approximately 58.06M, accounting for 116.62% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -10575638.00.